Medicago

The federal government isn't considering putting up money to help buy shares in the only domestic manufacturer of COVID-19 vaccines, but it is "working on a solution" with Medicago's parent company.

Canada is about to toss more than half of its doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad.

Canada may not be able to donate millions of doses of the only COVID-19 vaccine made in the country because the World Health Organization is leaning against granting it an emergency-use licence.

Known as Covifenz, the vaccine was developed by Medicago, a biotechnology company based in Quebec City that uses a plant host to make virus−like particles which help the body’s immune system make antibodies.  

Canada's first homegrown vaccine for COVID-19 is showing promising antibody results in hundreds of participants in a Phase 2 trial and could be ready for a final authorization request this summer.

A homegrown mRNA vaccine for COVID-19 shows promising results in its first small trial and its maker is hoping to test it directly against the vaccine from Pfizer-BioNTech.

The federal government is ordering more than 75 million syringes, alcohol swabs and bandages so it can inoculate Canadians as soon as a COVID-19 vaccine is ready.